A new data network that integrates emerging research on the molecular makeup of diseases with clinical data on individual patients could drive the development of a more accurate classification of disease and ultimately enhance diagnosis and treatment, according to a new report from the National Research Council.

Biomedical research institution Coriell Institute for Medical Research has partnered with Ohio State University (OSU) Medical Center physicians to incorporate genetic risk information into their patients' EMRs, through their participation in the Coriell Personalized Medicine Collaborative (CPMC) research study. The goal of the CPMC study is to understand the utility of genome information in patient care and develop best practices for the field.